phrykt

Opko Health, Inc. (OPK): who owns it and who trades it

As of Nov 16, 2026, OPK insiders reported 2 open-market sales worth $24.6K and 33 purchases worth $3M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was John A Paganelli (Director), with $24.6K. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Opko Health

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns OPK

222 funds and institutions reported OPK shares worth $309M at the end of Q2 2026, about 27% of the company. The largest holder is Rubric Capital Management LP with 6.3%.

Funds and institutions (13F) 27%Everyone else 73%

10 largest owners, by share of the company

Rubric Capital Management LP6.3%
BlackRock, Inc.4.9%
Vanguard Capital Management LLC2.0%
Vanguard Portfolio Management LLC2.0%
Geode Capital Management, LLC1.5%
State Street Corp1.4%
Goldman Sachs Group Inc0.9%
UBS Group AG0.7%
Whitefort Capital Management, LP0.6%
Northern Trust Corp0.5%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Rubric Capital Management LP47.79M6.33%$71.7MNo change
BlackRock, Inc.36.98M4.90%$55.5M+2%
Vanguard Capital Management LLC14.97M1.98%$22.5M+3%
Vanguard Portfolio Management LLC14.93M1.98%$22.4M+1%
Geode Capital Management, LLC11.58M1.53%$17.4M+2%
State Street Corp10.31M1.37%$15.5M+9%
Goldman Sachs Group Inc7.04M0.93%$10.6M-8%
UBS Group AG5.01M0.66%$7.5M-18%
Whitefort Capital Management, LP4.51M0.60%$6.8M+6%
Northern Trust Corp3.76M0.50%$5.6M+4%
Charles Schwab Investment Management Inc3.60M0.48%$5.4M+1%
Sixth Street Partners Management Company, L.P.3.60M0.48%$5.4M–
Highbridge Capital Management LLC3.59M0.48%$5.4M–
Vanguard Fiduciary Trust Co2.71M0.36%$4.1M-1%
AWM Investment Company, Inc.2.11M0.28%$3.2M+0%
Morgan Stanley1.98M0.26%$3M+65%
California State Teachers Retirement System1.44M0.19%$961K+248%
Citadel Advisors LLC1.42M0.19%$2.1M-32%
Washington Growth Strategies LLC1.36M0.18%$2MNo change
Bank of New York Mellon Corp1.33M0.18%$2M+4%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, OPK insiders reported $3M of open-market purchases and $24.6K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$3M
33 trades, 2 people
Sales, 12 months
$24.6K
2 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 5, 2026
Filed Nov 5, 2026

Purchases and sales by month

$24.6K$24.6KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 5, 2026John A PaganelliDirectorSale4,426$1.78$7.9KForm 4
Nov 5, 2026John A PaganelliDirectorSale9,175$1.82$16.7KForm 4
Mar 20, 2026John A PaganelliDirectorPurchase10,000$1.14$11.4KForm 4
Nov 21, 2025Frost Gamma Investments Trust +110% ownerPurchase89,375$1.33$119KForm 4
Nov 21, 2025Frost Gamma Investments Trust +110% ownerPurchase191,490$1.33$255KForm 4
Nov 21, 2025Frost Gamma Investments Trust +110% ownerPurchase3,894$1.32$5.1KForm 4
Nov 21, 2025Frost Gamma Investments Trust +110% ownerPurchase102,371$1.30$133KForm 4
Nov 21, 2025Frost Gamma Investments Trust +110% ownerPurchase192,870$1.34$258KForm 4
Nov 20, 2025Frost Gamma Investments Trust +110% ownerPurchase161,818$1.34$217KForm 4
Nov 20, 2025Frost Gamma Investments Trust +110% ownerPurchase24,579$1.34$32.9KForm 4
Nov 20, 2025Frost Gamma Investments Trust +110% ownerPurchase1,757$1.35$2.4KForm 4
Nov 20, 2025Frost Gamma Investments Trust +110% ownerPurchase211,948$1.33$282KForm 4
Nov 20, 2025Frost Gamma Investments Trust +110% ownerPurchase119,129$1.32$157KForm 4
Nov 20, 2025Frost Gamma Investments Trust +110% ownerPurchase47,105$1.33$62.6KForm 4
Nov 20, 2025Frost Gamma Investments Trust +110% ownerPurchase13,664$1.35$18.4KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase21,236$1.30$27.6KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase198,904$1.32$263KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase36,325$1.28$46.5KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase58,160$1.29$75KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase300$1.29$387Form 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase155,496$1.32$205KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase30,082$1.30$39.1KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase12,993$1.31$17KForm 4
Nov 19, 2025Frost Gamma Investments Trust +110% ownerPurchase66,504$1.31$87.1KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase212,608$1.28$272KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase1,772$1.27$2.3KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase15,000$1.27$19.1KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase66,635$1.26$84KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase49,590$1.25$62KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase410$1.25$512Form 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase33,572$1.29$43.3KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase1$1.29$1Form 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase83,556$1.29$108KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase69,728$1.28$89.3KForm 4
Nov 18, 2025Frost Gamma Investments Trust +110% ownerPurchase428$1.28$548Form 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Frost Gamma Investments Trust10% owner$3M–Nov 21, 2025
John A PaganelliDirector$11.4K$24.6KNov 5, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

OPK short interest

Low short interest. 4.4% of OPK shares are sold short: about 1 share in 23. Over the last 12 reports the number of shares short went up 1%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 32.85M OPK shares were sold short, 4.4% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 3.56M shares, buying them all back would take about 9.2 trading days (days to cover).

Shares short, % of all shares

4.42%May 15Oct 304.90%

Days to cover

9.2May 15Oct 3018.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202632.85M4.42%-3%3.56M9.2
Oct 15, 202634.01M4.56%-4%6.47M5.3
Sep 30, 202635.56M4.76%-1%2.38M14.9
Sep 15, 202635.99M4.82%+4%3.41M10.6
Aug 31, 202634.56M4.63%+3%2.51M13.8
Aug 14, 202633.65M4.51%+2%2.72M12.4
Jul 31, 202632.88M4.41%-2%6.10M5.4
Jul 15, 202633.64M4.46%+3%2.60M13.0
Jun 30, 202632.59M4.32%-1%3.65M8.9
Jun 15, 202632.79M4.34%-1%2.77M11.8
May 29, 202633.04M4.38%+1%3.03M10.9
May 15, 202632.66M4.32%-3%1.97M16.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Opko Health company events

Opko Health filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Oct 15, 2026AgreementOPKO Health, Inc., a Delaware corporation, its wholly owned subsidiary, BioReference Health, LLC, and Laboratory Corporation of America Holdings, a Delaware corporation, entered into an Asset Purchase Agreement. Filing
  3. Oct 2, 2026AnnouncementOPKO Health, Inc. determined that its 3.75% Convertible Senior Notes due 2029, of which approximately $121 million is outstanding, are convertible by holders of such Notes through December 31, 2026. Filing
  4. Aug 14, 2026AgreementOPKO Health, Inc. entered into an amendment to the initial Note Purchase Agreement dated July 17, 2024 (the “Original Agreement”; and as amended by the Amendment, the “Amended Agreement”) with certain purchasers party thereto from time to time, its wholly-owned subsidiaries OPKO Biologics Ltd. and… Filing
  5. Jul 27, 2026ResultsReleased financial results. Filing
  6. Jun 18, 2026VoteReported shareholder vote results. Filing
  7. Apr 28, 2026ResultsReleased financial results. Filing
  8. Mar 19, 2026LeadershipThe Board of Directors of OPKO Health, Inc., appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company’s 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation. Filing
  9. Feb 26, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Opko Health financials

Famous investors that hold OPK

5 of the 50 well-known investors we track reported holding OPK in their latest 13F filing. The largest position is Ken Griffin's, worth $4.5M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20262.77M$4.5M0.0%+95%
Jim Simons · Renaissance TechnologiesQ3 20261.01M$1.6M0.0%New
Paul Tudor Jones · Tudor Investment CorpQ3 2026244,821$394K0.0%No change
Steve Cohen · Point72 Asset ManagementQ3 2026242,987$391K0.0%+67%
Israel Englander · Millennium ManagementQ3 2026137,297$221K0.0%+90%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Opko Health, Inc. (OPK) stock

Who owns the most OPK stock?

The largest reported owner of Opko Health, Inc. (OPK) is Rubric Capital Management LP, with 6.3% of the company. In total, 222 funds and institutions reported holding OPK at the end of Q2 2026, together about 27% of the shares. See the largest owners.

Are OPK insiders buying or selling?

In the last 12 months, OPK insiders reported 33 open-market purchases worth $3M and 2 sales worth $24.6K. The latest trade was on Nov 5, 2026. See every trade.

What is the short interest in OPK?

As of Oct 30, 2026, 32.85M OPK shares were sold short, 4.4% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 3.56M shares, buying them all back would take about 9.2 trading days (days to cover). See the history.

Which famous investors hold OPK?

5 of the 50 well-known investors we track reported OPK in their latest 13F filing, including Ken Griffin, Jim Simons, Paul Tudor Jones. The largest position is worth $4.5M. See all holders.

Executive pay

Opko Health's chief executive was paid a total of $1.9M for the year ended Dec 31, 2025, down 14% from $2.2M the year before. In the last 12 months, Opko Health's executives and directors bought $11.4K of stock on the open market and sold $24.6K.

Chief executive, total pay$1.9MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$1.3MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.7MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.